Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
ANTARES PHARMA, INC. (ATRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/03/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/26/2022 |
4
| ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 118,392 shares
@ $5.6, valued at
$663k
Disposed/sold 49,425 shares
@ $5.6, valued at
$276.8k
Disposed/sold 20,000 options to buy
@ $4.54, valued at
$90.8k
Disposed/sold 61,930 options to buy
@ $3.09, valued at
$191.4k
Disposed/sold 99,395 options to buy
@ $2.18, valued at
$216.7k
Disposed/sold 150,000 options to buy
@ $1.12, valued at
$168k
Disposed/sold 80,318 options to buy
@ $2.66, valued at
$213.6k
Disposed/sold 76,548 options to buy
@ $2.7, valued at
$206.7k
Disposed/sold 46,729 options to buy
@ $2.92, valued at
$136.4k
Disposed/sold 58,246 options to buy
@ $2.73, valued at
$159k
Disposed/sold 48,542 options to buy
@ $4.42, valued at
$214.6k
|
|
| 05/26/2022 |
4
| GUETH ANTON (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 386,132 shares
@ $5.6, valued at
$2.2M
Disposed/sold 1,800 shares
@ $5.6, valued at
$10.1k
Disposed/sold 79,645 shares
@ $5.6, valued at
$446k
Disposed/sold 61,930 options to buy
@ $3.09, valued at
$191.4k
Disposed/sold 99,395 options to buy
@ $2.18, valued at
$216.7k
Disposed/sold 150,000 options to buy
@ $1.12, valued at
$168k
Disposed/sold 80,318 options to buy
@ $2.66, valued at
$213.6k
Disposed/sold 76,548 options to buy
@ $2.7, valued at
$206.7k
Disposed/sold 46,729 options to buy
@ $2.92, valued at
$136.4k
Disposed/sold 58,246 options to buy
@ $2.73, valued at
$159k
Disposed/sold 48,542 options to buy
@ $4.42, valued at
$214.6k
|
|
| 05/26/2022 |
4
| Richardson Peter C (See Remarks) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 36,199 shares
@ $5.6, valued at
$202.7k
Disposed/sold 14,414 shares
@ $5.6, valued at
$80.7k
Disposed/sold 59,179 options to buy
@ $4.01, valued at
$237.3k
Disposed/sold 69,037 options to buy
@ $4.42, valued at
$305.1k
|
|
| 05/26/2022 |
4
| Smith Karen L. (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 54,193 shares
@ $5.6, valued at
$303.5k
Disposed/sold 25,452 shares
@ $5.6, valued at
$142.5k
Disposed/sold 20,000 options to buy
@ $3.72, valued at
$74.4k
Disposed/sold 46,729 options to buy
@ $2.92, valued at
$136.4k
Disposed/sold 58,246 options to buy
@ $2.73, valued at
$159k
Disposed/sold 48,542 options to buy
@ $4.42, valued at
$214.6k
|
|
| 05/26/2022 |
4
| JACOB LEONARD S (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 138,901 shares
@ $5.6, valued at
$777.8k
Disposed/sold 31,674 shares
@ $5.6, valued at
$177.4k
Disposed/sold 123,860 options to buy
@ $3.09, valued at
$382.7k
Disposed/sold 198,789 options to buy
@ $2.18, valued at
$433.4k
Disposed/sold 300,000 options to buy
@ $1.12, valued at
$336k
Disposed/sold 160,636 options to buy
@ $2.66, valued at
$427.3k
Disposed/sold 153,097 options to buy
@ $2.7, valued at
$413.4k
Disposed/sold 73,431 options to buy
@ $2.92, valued at
$214.4k
Disposed/sold 77,662 options to buy
@ $2.73, valued at
$212k
Disposed/sold 60,407 options to buy
@ $4.42, valued at
$267k
|
|
| 05/26/2022 |
4
| GRAHAM PETER J (See Remarks) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 414,470 shares
@ $5.6, valued at
$2.3M
Disposed/sold 202,139 shares
@ $5.6, valued at
$1.1M
Disposed/sold 124,234 shares
@ $5.6, valued at
$695.7k
Disposed/sold 125,000 options to buy
@ $2.29, valued at
$286.3k
Disposed/sold 212,900 options to buy
@ $1.12, valued at
$238.4k
Disposed/sold 217,725 options to buy
@ $2.66, valued at
$579.1k
Disposed/sold 177,453 options to buy
@ $2.7, valued at
$479.1k
Disposed/sold 170,227 options to buy
@ $2.92, valued at
$497.1k
Disposed/sold 254,165 options to buy
@ $2.73, valued at
$693.9k
Disposed/sold 163,963 options to buy
@ $4.42, valued at
$724.7k
|
|
| 05/26/2022 |
4
| GARRITY THOMAS J (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 224,406 shares
@ $5.6, valued at
$1.3M
Disposed/sold 25,452 shares
@ $5.6, valued at
$142.5k
Disposed/sold 61,930 options to buy
@ $3.09, valued at
$191.4k
Disposed/sold 99,395 options to buy
@ $2.18, valued at
$216.7k
Disposed/sold 80,318 options to buy
@ $2.66, valued at
$213.6k
Disposed/sold 76,548 options to buy
@ $2.7, valued at
$206.7k
Disposed/sold 46,729 options to buy
@ $2.92, valued at
$136.4k
Disposed/sold 58,246 options to buy
@ $2.73, valued at
$159k
Disposed/sold 48,542 options to buy
@ $4.42, valued at
$214.6k
|
|
| 05/26/2022 |
4
| Powell Fred M (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 587,014 shares
@ $5.6, valued at
$3.3M
Disposed/sold 204,022 shares
@ $5.6, valued at
$1.1M
Disposed/sold 124,234 shares
@ $5.6, valued at
$695.7k
Disposed/sold 150,000 options to buy
@ $1.76, valued at
$264k
Disposed/sold 217,725 options to buy
@ $2.66, valued at
$579.1k
Disposed/sold 177,453 options to buy
@ $2.7, valued at
$479.1k
Disposed/sold 181,575 options to buy
@ $2.92, valued at
$530.2k
Disposed/sold 254,165 options to buy
@ $2.73, valued at
$693.9k
Disposed/sold 163,963 options to buy
@ $4.42, valued at
$724.7k
|
|
| 05/26/2022 |
4
| APPLE ROBERT F (President and CEO) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 1,876,693 shares
@ $5.6, valued at
$10.5M
Disposed/sold 611,667 shares
@ $5.6, valued at
$3.4M
Disposed/sold 374,099 shares
@ $5.6, valued at
$2.1M
Disposed/sold 21,658 options to buy
@ $4.26, valued at
$92.3k
Disposed/sold 56,300 options to buy
@ $3.09, valued at
$174k
Disposed/sold 288,786 options to buy
@ $2.18, valued at
$629.6k
Disposed/sold 773,700 options to buy
@ $1.12, valued at
$866.5k
Disposed/sold 725,751 options to buy
@ $2.66, valued at
$1.9M
Disposed/sold 591,510 options to buy
@ $2.7, valued at
$1.6M
Disposed/sold 567,423 options to buy
@ $2.92, valued at
$1.7M
Disposed/sold 776,617 options to buy
@ $2.73, valued at
$2.1M
|
|
| 05/26/2022 |
4
| Volkart Carmen B (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 55,916 options to buy
@ $3.48, valued at
$194.6k
|
|
| 05/26/2022 |
4
| Greenleaf Peter (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Disposed/sold 30,220 shares
@ $5.6, valued at
$169.2k
Disposed/sold 49,425 shares
@ $5.6, valued at
$276.8k
Disposed/sold 20,000 options to buy
@ $3.11, valued at
$62.2k
Disposed/sold 46,729 options to buy
@ $2.92, valued at
$136.4k
Disposed/sold 58,246 options to buy
@ $2.73, valued at
$159k
Disposed/sold 48,542 options to buy
@ $4.42, valued at
$214.6k
|
|
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/24/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|
|
|